Jim Palma, Executive Director at TargetCancer Foundation discusses a new clinical trial called TRACK (TargetRare Cancer Knowledge).
Keith Boettiger, President, Abbott Neuromodulation discusses the company's new Patient Controller app that is being integrated into their broader Neur...
Matthew Smith, MD, Professor of Medicine at Harvard Medical School and Director of the Genitourinary Malignancies Program at Massachusetts General Hospi...
Beto Casellas, CEO of CareCredit, a Synchrony solution, discusses the partnership with Salucro Healthcare Solutions. He talks about the financial impl...
Mark Campbell, PharmD, Vice President of Clinical Services for RxBenefits, a technology-enabled pharmacy benefits optimizer (PBO), discusses the company...
Joslyn Kirby, Associate Professor in the Department of Dermatology at Pennsylvania State University discusses an often misdiagnosed skin condition of hi...
Adam Bingaman, Director of Abdominal Organ Transplantation at Methodist Hospital/Specialty and Transplant in San Antonio, TX discusses tips for transpla...
Len Friedland, VP and Director, Scientific Affairs and Public Health Vaccines at GSK discusses the increase in vaccine preventable hepatitis A cases in ...
Shmuel Shoham, Associate Professor of Medicine at Johns Hopkins University School of Medicine discusses the multi-center, double-blind randomized contro...
Jim Doherty, CRO at Sage Therapeutics discuss the three clinical trials, one major depressive disorder (MDD), one postpartum depression (PPD) and one Es...